Fatty liver: Imaging patterns and pitfalls

Radiographics

Volumn 26, Issue 6, 2006, Pages 1637-1653

  Hamer, Okka W ^a   Aguirre, Diego A ^b   Casola, Giovanna ^c   Lavine, Joel E ^c   Woenckhaus, Matthias ^a   Sirlin, Claude B ^c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN SANTA FE DE BOGOTÁ   (Colombia)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; PRACTICE GUIDELINE; REVIEW;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DIAGNOSTIC IMAGING; FATTY LIVER; HUMANS; IMAGE ENHANCEMENT; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 34247465261     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.266065004     Document Type: Review

References (59)

1. Brunt EM, Tiniakos DG. Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:691-707.
2. Allard JP. Other disease associations with nonalcoholic fatty liver disease (NAFLD). Best Pract Res Clin Gastroenterol 2002;16:783-795.
3. Eaton S, Record CO, Bartlett K. Multiple biochemical effects in the pathogenesis of alcoholic fatty liver. Eur J Clin Invest 1997;27:719-722.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
5. Fargion S, Mattioli M, Fracanzani AL, et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:2448-2455.
6. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004.
7. Scheuer PJ, Lefkowitch JH. Fatty liver and lesions in the alcoholic. In: Liver biopsy interpretation. 6th ed. Philadelphia, Pa: Saunders, 2000; 111-129.
8. Wanless IR, Shiota K. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 2004;24:99-106.
9. Mendez-Sanchez N, Almeda-Valdes P, Uribe M. Alcoholic liver disease: an update. Ann Hepatol 2005;4:32-42.
10. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.
11. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-117.
12. el Hassan AY, Ibrahim EM, al Mulhim FA, Nabhan AA, Chammas MY. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992;65:774-778.
13. Kammen BF, Pacharn P, Thoeni RF, et al. Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol 2001;177:1035-1039.
14. Shen L, Fan JG, Shao Y, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003;9:1106-1110.
15. Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-226.
16. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988;27:142-149.
17. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15:539-543.
18. Jain KA, McGahan JP. Spectrum of CT and sonographic appearance of fatty infiltration of the liver. Clin Imaging 1993;17:162-168.
19. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.
20. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002;21:1023-1032.
21. Zwiebel WJ. Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MR 1995;16:8-15.
22. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980;137:727-729.
23. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004;230:276-280.
24. Hamer OW, Aguirre DA, Casola G, Sirlin CB. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 2005;237:159-169.
25. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol 1983;18:743-747.
26. Yajima Y, Narui T, Ishii M, et al. Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number. Tohoku J Exp Med 1982;136:337-342.
27. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113.
28. Johnston RJ, Stamm ER, Lewin JM, Hendrick RE, Archer PG. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdom Imaging 1998;23:409-415.
29. Jacobs JE, Birnbaum BA, Shapiro MA, et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR Am J Roentgenol 1998;171:659-664.
30. Kreft BP, Tanimoto A, Baba Y, et al. Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging 1992;2:463-471.
31. Rinella ME, McCarthy R, Thakrar K, et al. Dualecho, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 2003;9:851-856.
32. Venkataraman S, Braga L, Semelka RC. Imaging the fatty liver. Magn Reson Imaging Clin N Am 2002;10:93-103.
33. Martin J, Puig J, Falco J, et al. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging. Radiology 1998;207:325-330.
34. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 2005;237:1048-1055.
35. Rofsky NM, Weinreb JC, Ambrosino MM, Safir J, Krinsky G. Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 1996;20:230-235.
36. Thu HD, Mathieu D, Thu NT, Derhy S, Vasile N. Value of MR imaging in evaluating focal fatty infiltration of the liver: preliminary study. RadioGraphics 1991;11:1003-1012.
37. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994;12:487-495.
38. Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver: quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993;28:297-302.
39. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:E462-E468.
40. Choji T. Evaluation of fatty liver changes and fatty degeneration in liver tumors by 1H-MRS [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 1993;53:1408-1414.
41. Gabata T, Matsui O, Kadoya M, et al. Aberrant gastric venous drainage in a focal spared area of segment IV in fatty liver: demonstration with color Doppler sonography. Radiology 1997;203:461-463.
42. Kawamori Y, Matsui O, Takahashi S, Kadoya M, Takashima T, Miyayama S. Focal hepatic fatty infiltration in the posterior edge of the medial segment associated with aberrant gastric venous drainage: CT, US, and MR findings. J Comput Assist Tomogr 1996;20:356-359.
43. Kobayashi S, Matsui O, Kadoya M, et al. CT arteriographic confirmation of focal hepatic fatty infiltration adjacent to the falciform ligament associated with drainage of inferior vein of Sappey: a case report. Radiat Med 2001;19:51-54.
44. Matsui O, Kadoya M, Takahashi S, et al. Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. AJR Am J Roentgenol 1995;164:1137-1140.
45. Rubaltelli L, Savastano S, Khadivi Y, Stramare R, Tregnaghi A, Da Pian P. Targetlike appearance of pseudotumors in segment IV of the liver on sonography. AJR Am J Roentgenol 2002;178:75-77.
46. Itai Y, Saida Y. Pitfalls in liver imaging. Eur Radiol 2002;12:1162-1174.
47. Hoshiba K, Demachi H, Miyata S, et al. Fatty infiltration of the liver distal to a metastatic liver tumor. Abdom Imaging 1997;22:496-498.
48. Fregeville A, Couvelard A, Paradis V, Vilgrain V, Warshauer DM. Metastatic insulinoma and glucagonoma from the pancreas responsible for specific peritumoral patterns of hepatic steatosis secondary to local effects of insulin and glucagon on hepatocytes. Gastroenterology 2005;129:1150, 1365.
49. Sohn J, Siegelman E, Osiason A. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 2001;176:471-474.
50. Kroncke TJ, Taupitz M, Kivelitz D, et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 2000;10:1095-1100.
51. Kemper J, Jung G, Poll LW, Jonkmanns C, Luthen R, Moedder U. CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging 2002;27:708-710.
52. Monill JM, Martinez-Noguera A, Montserrat E, Sabate JM. Multifocal hepatic steatosis in HIV infection. AJR Am J Roentgenol 1999;172:839.
53. Khalili K, Lan FP, Hanbidge AE, Muradali D, Oreopoulos DG, Wanless IR. Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence. AJR Am J Roentgenol 2003;180:1601-1604.
54. Lawson TL, Thorsen MK, Erickson SJ, Perret RS, Quiroz FA, Foley WD. Periportal halo: a CT sign of liver disease. Abdom Imaging 1993;18:42-46.
55. Diaz Candamio MJ, Pombo F, Pombo S, Gonzales J, Rodriguez E. Diffuse periportal pathology on CT: differential diagnosis. Presented as scientific exhibit no. 10027 at the European Congress of Radiology, Vienna, Austria, 1999. http://www.ecr.org/Conferences/ECR1999/sciprg/abs/p010027.htm. Accessed August 24, 2004.
56. Mortele KJ, Stubbe J, Praet M, Van Langenhove P, De Bock G, Kunnen M. Intratumoral steatosis in focal nodular hyperplasia coinciding with diffuse hepatic steatosis: CT and MRI findings with histologic correlation. Abdom Imaging 2000;25:179-181.
57. Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. RadioGraphics 2005;25:321-331.
58. Tang Y, Yamashita Y, Ogata I, et al. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance. Radiat Med 1999;17:265-270.
59. Halvorsen RA, Korobkin M, Foster WL, Silverman PM, Thompson WM. The variable CT appearance of hepatic abscesses. AJR Am J Roentgenol 1984;142:941-946.